ATLAS / Macro Radar / Reporting / RXRX

RECURSION PHARMACEUTICALS, INC. (RXRX) reporting calendar

RECURSION PHARMACEUTICALS, INC. files periodic reports with the SEC as RXRX on Nasdaq. Atlas tracks 21 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
24 Jul 2026 – 17 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
6 May 2026
Reports on record
21

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 36 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open RXRX market profile Latest filing on SEC EDGAR ↗ Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20266 May 202636 days0001601830-26-000078
10-K31 Dec 202525 Feb 202656 days0001601830-26-000039
10-Q30 Sep 20255 Nov 202536 days0001601830-25-000166
10-Q30 Jun 20255 Aug 202536 days0001601830-25-000127
10-Q31 Mar 20255 May 202535 days0001601830-25-000075
10-K31 Dec 202428 Feb 202559 days0001601830-25-000035
10-Q30 Sep 20246 Nov 202437 days0001601830-24-000196
10-Q30 Jun 20248 Aug 202439 days0001601830-24-000115
10-Q31 Mar 20249 May 202439 days0001601830-24-000052
10-K31 Dec 202329 Feb 202460 days0001601830-24-000019
10-Q30 Sep 20239 Nov 202340 days0001601830-23-000069
10-Q30 Jun 20238 Aug 202339 days0001601830-23-000057
10-Q31 Mar 20238 May 202338 days0001601830-23-000023
10-K31 Dec 202227 Feb 202358 days0001601830-23-000010
10-Q30 Sep 20228 Nov 202239 days0001601830-22-000035
10-Q30 Jun 20229 Aug 202240 days0001601830-22-000030
10-Q31 Mar 202210 May 202240 days0001601830-22-000024
10-K31 Dec 202123 Mar 202282 days0001601830-22-000012
10-Q30 Sep 202110 Nov 202141 days0001601830-21-000023
10-Q30 Jun 202113 Aug 202144 days0001601830-21-000017
10-Q31 Mar 202112 May 202142 days0001601830-21-000007

Source: SEC EDGAR company submissions for CIK 0001601830. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.